Nova Scotia cannabis producer Aqualitas has been sold to a British company.
The Brooklyn-based firm has been bought by the London-based Cannaray Limited. Aqualitas will become part of Cannaray’s medical cannabis division, Therismos, which operates in Germany and the UK.
Co-founder and CEO Myrna Gillis said Thursday the deal started being hashed out three years ago. She said jobs are safe at the plant in Brooklyn. “It’s a great thing for the plant here in Brooklyn,” she said in an interview.
“We have expansion plans that had been on the books for a while, because we effectively had more demand than we had supply or capacity to meet. And we have funds that are earmarked now under this agreement for expansion, so we’re going to have expansion in the Liverpool facility. It enhances our position in relation to jobs and we don’t have any expectation of any layoffs.”
